Navigation Links
Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications
Date:4/17/2008

WOODCLIFF LAKE, N.J., April 17 /PRNewswire/ -- Eisai Corporation of North America today announces the immediate appointment of Robert Laverty as Vice President of U.S. Corporate Communications. In this newly created position, Mr. Laverty will be responsible for overseeing and coordinating all of Eisai's corporate communications strategies and activities in the United States.

Mr. Laverty brings to Eisai more than 22 years of global corporate, product, policy and research and development communications experience in the pharmaceutical industry. Most recently, he served as Vice President, Global Communications, Malaria Initiatives for Novartis AG, where he oversaw all global communications supporting the company's malaria initiative in the developing world. In addition, Mr. Laverty has held several other executive titles at Novartis Pharmaceuticals Corp, including Vice President, External Communication and Vice President, Global Pharma Media Relations.

Earlier in his career, Mr. Laverty held a number of progressively responsible positions in corporate policy, corporate affairs, and product public affairs at Bristol-Myers Squibb Company. He holds a Bachelor of Science degree in pharmacy from St. John's University, Jamaica, New York.

"Mr. Laverty is a welcome addition to our company and will be instrumental in strengthening Eisai's visibility and presence in the U.S. as a top-20 pharmaceutical company," said Lonnel Coats, President & COO, Eisai Corporation of North America. "With his more than two decades of senior communications expertise in the global pharmaceutical industry, Mr. Laverty's contributions to our company will be invaluable, as we continue to fulfill our human health care (hhc) mission to satisfy unmet medical needs and increase benefits to patients and their families."

About Eisai Corporation of North America

Eisai Corporation of North America is a wholly-owned subsidiary of Eisai Co., Ltd. and supports the activi
'/>"/>

SOURCE Eisai Corporation of North America
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. DARA Announces Surgi-Vision Agreement with Boston Scientific Corporation
2. Torchmark Corporation Reports First Quarter 2008 Results
3. Digirad Corporation to Release First Quarter Financial Results on April 24, 2008
4. Otter Tail Corporation Holds 2008 Annual Meeting: Shareholders Elect Directors; Board Declares Quarterly Dividend
5. Microflex Corporation Launches New Website
6. Linkwell Corporation Selected to Train and License all Disinfectant and Pest Control Professionals in China and for the Beijing Olympics
7. Zipfizz(R) Announces Distribution Deal With the Odom Corporation
8. Alsius Corporation Awarded Three-Year Agreement With MedAssets Supply Chain Systems
9. BioElectronics Corporations New Commercial Airing Nationally Advertising Initiative Will Reach 15,000,000 Homes Nationwide
10. Linkwell Corporation Year-End 2007 Earnings Release and Conference Call Notice
11. Albemarle Corporations First Quarter 2008 Earnings Conference Call To Be Held April 22, 2008 at 8:00am ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)... Though the number of jobs created i... companies reported a different kind of slowdown: ...s months. , Seattle, WA (...created in the medical field slowed in June overal...ind of slowdown that will be music to the ears of ...
(Date:7/25/2008)... supporting the US Department of Defense and Feder... Phoenix. Operation Golden Phoenix is a, four-da...ned to assist, federal, state and local agencies w...os. Dataline is providing a vital, ad-hoc, secure ... use during the exercise., NORFOLK, Va., July 25 ...
(Date:7/25/2008)...elationship Based on Significant Improvements in M...MDdatacor, Inc., a leader in health,care quality m..., today,announced it has entered into a long-term ...rt Wellmark,s Collaboration on Quality(SM) Incent ...ion between Wellmark and,primary care clinicians t...
(Date:7/25/2008)...URG, Ill., July 25 /PRNewswire/ -- Sagent Pharmace...utical company, today announced that it,has launch...arrhythmic,indicated for the treatment and prophyl...ion and hemodynamically unstable ventricular,tachy... heart beat.,Sagent,s amiodarone HCl injection wil...
Breaking Medicine News(10 mins):Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3
...ldren can be treated effectively with a single dos...ajor global health problem particularly in // chil...resource-limited countries where cholera occurs, a...tant as it reduces the demands on the healthcare s...
... effective in prevent the brain damages similar to...th Florida have found that a component of green te...ns of mice genetically programmed to develop the n... component, called epigallocatechin-3-gallate (EGC...
...t smoking is injurious to health. The maximum harm...cts of smoking may be understood by the effect it ...xidase A (MAOA) is important in mood regulation an... regulate blood pressure. In a new study, research...
...hange the curriculum for medicine by integrating m...ment it within two years. "Today's medical curric...ation of both the modern and traditional practices... to come out within two years time," said health m...
Other Medicine News:
(Date:7/24/2008)...gned to take body temperature, for home,and clinic...ll/ --- Kidz-Med, Inc.,(subsidiary of American Sci...States distributor of the Thermofocus(R) 5-in-1 no...results of a clinical study,conducted by the Secon...,Milan, Italy, which proves that the Thermofocus(R...
(Date:7/23/2008)...-- Sound Pharmaceuticals (SPI) has filed,an Invest...e clinical,testing of a proprietary formulation of...d hearing loss or ototoxicity. The oral capsule,co...nced stage lung cancer,and head and neck cancer pa... marks the second development program for SPI to e...
(Date:7/23/2008)...irstCall/ -- Dendreon Corporation,(Nasdaq: DNDN )...ata,Monitoring Committee (IDMC) to review in Octob...elating to the Company,s Phase 3 IMPACT (IMmunothe...nown as D9902B) clinical trial,of PROVENGE(R) (sip...nal,active cellular immunotherapy for the treatmen...
(Date:7/22/2008)...cs Development Initiative bring MJFF,s,current act...anuary 20,2009, NEW YORK, July 22 /PRNewswire-US...ery of transformative treatments and a cure for Pa...or Parkinson,s Research has awarded,$2.7 million i...e awards,were granted under MJFF,s Therapeutics De...
Breaking Medicine Technology:Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Grubb 26 Ellis Healthcare REIT Acquires Park Place Office Park in Dayton Ohio 8925 1Grubb 26 Ellis Healthcare REIT Acquires Park Place Office Park in Dayton Ohio 8925 2Grubb 26 Ellis Healthcare REIT Acquires Park Place Office Park in Dayton Ohio 8925 3DNC 3A Rudy Shows Again Hes Out of Touch With Americas Priorities 8922 1DNC 3A Rudy Shows Again Hes Out of Touch With Americas Priorities 8922 2DNC 3A Rudy Shows Again Hes Out of Touch With Americas Priorities 8922 3Risk of HIV West Nile Virus E Coli Transmission May be Reduced Through Improved Blood Screening Methods 8918 1Risk of HIV West Nile Virus E Coli Transmission May be Reduced Through Improved Blood Screening Methods 8918 2Holiday Travel Bad Eating Habits a Recipe for Stomach Trouble 8916 1Holiday Travel Bad Eating Habits a Recipe for Stomach Trouble 8916 2
...RIDGE, Mass.--(BUSINESS WIRE)--Jun 14, 2007 - Comb...ed the presentation of,additional data related to ...2 and CRx-139, at the European League Against,Rheu...ting, June,13-16, 2007 in Barcelona, Spain., CRx-1...e and Chondrocyte,Inflammatory Mediators by CRx-10...
...FORD, Conn.--(BUSINESS WIRE)--Jun 13, 2007 - Neuro...t data from previous,Phase 1 and Phase 2a clinical...or the treatment of insomnia, were presented in tw... Associated,Professional Sleep Societies (APSS) in...dies with NG2-73 in chronic insomnia patients,are ...
Other Medicine Technology:Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 2Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 3Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 4Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 2Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 3Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 4Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 5
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: